Literature DB >> 8958194

Selective slow pathway ablation in atrioventricular nodal reentrant tachycardia--comparison of different methods and the site of slow pathway ablation.

K Chiyoda1, Y Kobayashi, Y Jinbo, A Miyata, H Nakagawa, K Tanno, K Kurano, S Kikushima, T Baba, H Mukai, T Katagiri.   

Abstract

The optimum potential of the slow pathway (SP) was investigated by determining the effectiveness and safety of high-radiofrequency catheter ablation to treat atrioventricular nodal reentrant tachycardia (AVNRT). The subjects consisted of 29 patients with AVNRT (11 men, with a mean age of 54 +/- 15 years). Three ablation methods were used: a) Method A used the earliest atrial activation site, which is retrograde to the slow pathway, b) Method SP used the SP potential, and c) Method SW, in which ablation was performed stepwise starting from the coronary sinus and moving toward the recording site of the His bundle potential. Five, 20, and 4 patients underwent Methods A, SP, and SW, respectively. The fewest number of applications was needed with Method SP (11 +/- 9, 6 +/- 4, and 13 +/- 9), and the delivered energy was also lowest with Method SP (9151 +/- 6119, 3712 +/- 2168, and 12183 +/- 4090 J, with Methods A, SP, and SW, respectively). In Method SP, the interval between the atrium and SP was significantly longer at sites which cured tachycardia, than at sites at which ablation was ineffective (88 +/- 26 vs 66 +/- 22 msec, p < 0.05). The SP potential showed a humped shape in 18 of 20 patients. Method SP was the most efficient ablation method for treating AVNRT.

Entities:  

Mesh:

Year:  1996        PMID: 8958194     DOI: 10.1253/jcj.60.861

Source DB:  PubMed          Journal:  Jpn Circ J        ISSN: 0047-1828


  1 in total

1.  Recognition of inferiorly dislocated fast pathways guided by three-dimensional electro-anatomical mapping.

Authors:  Satoko Tanaka; Akihiro Yoshida; Koji Fukuzawa; Asumi Takei; Gaku Kanda; Kaoru Takami; Hiroyuki Kumagai; Mitsuru Takami; Mitsuaki Itoh; Kimitake Imamura; Ryudo Fujiwara; Ken-Ichi Hirata
Journal:  J Interv Card Electrophysiol       Date:  2011-06-24       Impact factor: 1.900

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.